SG
Susmita Ghosh
The University of Texas MD Anderson Cancer Center, University of Calcutta - Rajabazar Science College Campus, Presidency University, South Calcutta Girls' College
0000-0001-6591-9147
Employment
-
The University of Texas MD Anderson Cancer Center Research Investigator2023 - 2024
-
The University of Texas MD Anderson Cancer Center Postdoctoral fellow2020 - 2023
Education
-
University of Calcutta - Rajabazar Science College Campus Ph.D. in Science2013 - 2018
-
Presidency University M.Sc.2010 - 2012
-
South Calcutta Girls' College B.Sc. (Honors)2007 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (44)
- Supplementary Figure 1 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer Save
- Supplementary Figure 2 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer Save
- Supplementary Figure 3 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer Save
- Supplementary Figure 4 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer Save
- Supplementary Figure 5 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer Save
- Supplementary Figure 6 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer Save
- Supplementary File 1 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer Save
- Supplementary File 2 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer Save
- BRG1 (SMARCA4) Status Dictates the Response to EGFR Inhibitors in Wild-Type EGFR Non-Small Cell Lung Cancer Save
- Supplementary Figure 5 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer Save